Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $86.23M.
ENTERPRISE VALUE (EV)
$86.23M
Lantern Pharma Inc.
Market Cap
$12.12M
Enterprise Value (EV)
$86.23M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Lantern Pharma Inc. (LTRN) | $12.12M | $86.23M |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.31M | $4.48M |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.26M | $4.51M |
| IRIDEX Corporation (IRIX)vs › | $12.41M | $11.75M |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.21M | N/A |
| Biofrontera Inc. (BFRI)vs › | $11.13M | $13.97M |
| Dare Bioscience, Inc. (DARE)vs › | $12.58M | $6.72M |
| BioVie Inc. (BIVI)vs › | $11.01M | $2.31M |
| Cerenome, Inc. (CNSY)vs › | $10.98M | $8.66M |
| Cytosorbents Corporation (CTSO)vs › | $12.69M | $34.62M |
Market Cap
$12.12M
Total Debt
$78.54M
Cash
$4.42M
Enterprise Value
$86.23M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
